Crispr Therapeutics shares owned by Norris Financial Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Norris Financial Group
from 13F filings
Historical chart of Norris Financial Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Norris Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Norris Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $345k | 7.3k | 47.57 |
| 2025-12-31 | $411k | 7.8k | 52.44 |
| 2025-09-30 | $516k | 8.0k | 64.81 |
| 2025-06-30 | $473k | 9.7k | 48.64 |
| 2025-03-31 | $329k | 9.7k | 34.03 |
| 2024-12-31 | $258k | 6.6k | 39.36 |
| 2024-09-30 | $486k | 10k | 46.98 |
| 2024-06-30 | $546k | 10k | 54.01 |
| 2024-03-31 | $856k | 13k | 68.16 |
| 2023-12-31 | $931k | 15k | 62.60 |
| 2023-09-30 | $656k | 15k | 45.39 |
| 2023-06-30 | $679k | 12k | 56.14 |
| 2022-03-31 | $220k | 3.5k | 62.77 |